Simple tests could revolutionize chronic pain diagnosis
NCT ID NCT06518278
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study aims to improve how doctors diagnose and treat chronic muscle and joint pain by using simple questionnaires and pain sensitivity tests. Researchers will study 250 adults with conditions like osteoarthritis, fibromyalgia, chronic low back pain, or inflammatory arthritis. The goal is to better understand how the brain and nerves contribute to pain, leading to faster and more effective treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 250 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2024
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will include people with musculoskeletal pain attending NHS outpatient clinics and individuals who have consented to be contacted for future research from research databases at the University of Nottingham
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or over. * One for more of the following self-reported diagnoses: fibromyalgia, inflammatory MSK condition (e.g., rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis), low back pain, osteoarthritis. * MSK diagnosis and pain onset more than 3 months prior to baseline * Self-reported pain levels ≥ 3 on a 0 to 10 numerical rating scale where 0 = 'no pain' and 10 = 'worst pain imaginable' on most days in the 3 months before baseline. * Ability to give informed consent. Exclusion Criteria: * Terminal/uncontrolled medical or mental health condition that would prevent participants from completing assessments or pose a significant risk to participants or staff. * Insufficient understanding of spoken or written English to comply with the requirements of the study protocol. * Inability to adhere to the study protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Axial spondyloarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Nottingham, Academic Rheumatology, IRIS, School of Medicine
Nottingham, Nottingham, NG5 1PB, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can taekwondo kicks ease ankylosing spondylitis?
- Can naming your feelings predict back pain relief?
- Can a light bulb dial down chronic pain?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Why some days hurt more: charting Fibromyalgia's daily swings